Start: April 24, 2018
End: September 2021
The Overture Study is a Phase I/II clinical trial to study safety, adherence rates, and efficacy of the Active GammaSense Stimulation System in older adults with mild cognitive impairment (MCI) and Alzheimer's disease. The device provides noninvasive auditory and visual sensory stimulation to the brain.
Minimum Age: 55 Years
Maximum Age: N/A
Contact study personnel listed either under the general study contact or the location nearest you.
Lead: Cognito Therapeutics, Inc.
Source: ClinicalTrials.gov ID: NCT03556280